Matches in Wikidata for { <http://www.wikidata.org/entity/Q64149687> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64149687 description "clinical trial" @default.
- Q64149687 description "ensayu clínicu" @default.
- Q64149687 description "klinisch onderzoek" @default.
- Q64149687 description "клінічне випробування" @default.
- Q64149687 name "Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)" @default.
- Q64149687 type Item @default.
- Q64149687 label "Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)" @default.
- Q64149687 prefLabel "Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)" @default.
- Q64149687 P1132 Q64149687-05D2974E-E73A-463C-8941-B3AAF5822C92 @default.
- Q64149687 P1476 Q64149687-62D64010-7690-4B7E-8FAD-1383656CEA44 @default.
- Q64149687 P17 Q64149687-4F169B09-BBC4-4A47-BB27-3D2804E6C220 @default.
- Q64149687 P17 Q64149687-579D595D-C7B0-4353-A212-19E4E6C4BA6D @default.
- Q64149687 P17 Q64149687-6A337D95-5551-4EEA-91BE-7643EE8B3964 @default.
- Q64149687 P17 Q64149687-989D5B58-DD19-466D-AE36-F48A5D1037AC @default.
- Q64149687 P17 Q64149687-9F7FF2CC-33C7-46E8-BD7E-3E280FA59FE5 @default.
- Q64149687 P17 Q64149687-BDD9261C-19EF-40C9-A9CE-0E38250D2367 @default.
- Q64149687 P17 Q64149687-FECF0D7A-8166-470B-AED3-0D55313D0273 @default.
- Q64149687 P2899 Q64149687-16C769D3-A3B8-4F89-B89A-872ABF0428F9 @default.
- Q64149687 P3098 Q64149687-E1A4E75A-EBF7-4848-BC43-0F473B7F5329 @default.
- Q64149687 P31 Q64149687-2CA31988-A946-404B-B5E7-AE4CCE752112 @default.
- Q64149687 P4135 Q64149687-43925145-A042-462C-B02B-8DBF63506A4A @default.
- Q64149687 P4844 Q64149687-EAA25AE5-053A-4200-8C99-0D7AB8F27C60 @default.
- Q64149687 P580 Q64149687-371AC389-ADC2-4C15-9256-F638BCC1E676 @default.
- Q64149687 P582 Q64149687-B7A2DF87-7344-4E78-9888-A2C3D80E6C16 @default.
- Q64149687 P6099 Q64149687-5704B13F-1909-408F-9FCE-FC8FD52479E4 @default.
- Q64149687 P8363 Q64149687-C35F288A-309E-425D-AAE4-C50660D369CC @default.
- Q64149687 P1132 "+238" @default.
- Q64149687 P1476 "A Phase 4 Double-Blinded, Randomized, Active Comparator-Controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants" @default.
- Q64149687 P17 Q183 @default.
- Q64149687 P17 Q29 @default.
- Q64149687 P17 Q30 @default.
- Q64149687 P17 Q31 @default.
- Q64149687 P17 Q35 @default.
- Q64149687 P17 Q40 @default.
- Q64149687 P17 Q43 @default.
- Q64149687 P2899 "+2" @default.
- Q64149687 P3098 "NCT03351608" @default.
- Q64149687 P31 Q30612 @default.
- Q64149687 P4135 "+16" @default.
- Q64149687 P4844 Q411917 @default.
- Q64149687 P580 "2018-02-12T00:00:00Z" @default.
- Q64149687 P582 "2020-08-07T00:00:00Z" @default.
- Q64149687 P6099 Q42825046 @default.
- Q64149687 P8363 Q78089383 @default.